-
Uganda: Uganda Seeks to Start Injectable HIV Drugs
Monitor, 10 July 2017
The Joint Clinical Research Centre (JCRC) has applied to start trials on injectable HIV/Aids drugs. Read more »
Professor Peter Mugyenyi, executive director of the Joint Clinical Research Centre, says the clinical trials will see a person living with HIV receive a shot of antiretroviral treatment once every three months instead of taking tablets or capsules.
(file photo).
Dolutegravir is the drug of choice for people with HIV in high-income countries who have never taken antiretroviral therapy before and for those who have developed resistance to ... Read more »
The government has said Dolutegravir, the new drug for the treatment of HIV/AIDS, is already being used in Nigeria, although only by those who can afford it because of its high ... Read more »
AllAfrica publishes around 500 reports a day from more than 100 news organizations and over 500 other institutions and individuals, representing a diversity of positions on every topic. We publish news and views ranging from vigorous opponents of governments to government publications and spokespersons. Publishers named above each report are responsible for their own content, which AllAfrica does not have the legal right to edit or correct.
Articles and commentaries that identify allAfrica.com as the publisher are produced or commissioned by AllAfrica. To address comments or complaints, please Contact us.